Research Analysts Set Expectations for Roche FY2026 Earnings

Roche Holding AG (OTCMKTS:RHHBY) – Stock analysts at Erste Group Bank lifted their FY2026 earnings per share estimates for shares of Roche in a research report issued on Thursday, August 27th. Erste Group Bank analyst H. Engel now forecasts that the company will post earnings per share of $3.16 for the year, up from their prior forecast of $3.15. The consensus estimate for Roche’s current full-year earnings is $3.06 per share. Erste Group Bank also issued estimates for Roche’s FY2027 earnings at $3.42 EPS.

Several other research firms have also recently issued reports on RHHBY. Morgan Stanley upgraded shares of Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 price objective for the company in a research report on Friday, August 7th. HSBC lowered shares of Roche from a “buy” rating to a “hold” rating in a report on Monday, July 6th. Finally, Zacks Research upgraded shares of Roche from a “strong sell” rating to a “hold” rating in a report on Monday, August 24th. Five research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $60.00.

Roche Trading Down 1.1%

Shares of RHHBY stock opened at $53.09 on Monday. The company’s 50-day moving average price is $54.08 and its 200-day moving average price is $52.87. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.38 and a quick ratio of 1.12. Roche has a twelve month low of $39.50 and a twelve month high of $60.85.

Institutional Investors Weigh In On Roche

Institutional investors have recently modified their holdings of the company. Renasant Bank acquired a new position in Roche during the 2nd quarter worth about $210,000. North Star Asset Management Inc. purchased a new stake in Roche during the second quarter worth about $1,351,000. Puzo Michael J acquired a new stake in shares of Roche during the second quarter worth about $1,229,000. Fulton Bank N.A. lifted its position in shares of Roche by 5.1% during the second quarter. Fulton Bank N.A. now owns 11,572 shares of the company’s stock worth $597,000 after purchasing an additional 559 shares in the last quarter. Finally, GAMMA Investing LLC boosted its stake in shares of Roche by 14.3% in the second quarter. GAMMA Investing LLC now owns 29,015 shares of the company’s stock valued at $1,490,000 after purchasing an additional 3,625 shares during the period.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann?La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.